Abstract

We tested the hypothesis that Superoxide (O2·−) mediates Ang II-dependent increase in expression of smooth muscle α-actin (SMα-actin) gene in cultured renal preglomerular microvascular smooth muscle cells (PGSMCs) from SHR. O2·− quantified by lucigenin method was significantly increased by 85% in intact PGSMCs and by 47% in cell membranes at 12 hr after incubation with Ang II (1uM). Expression of SMα-actin mRNA determined by real time RT-PCR was enhanced by 81% by Ang II and inhibited by 50% in Ang II-treated cells by the thiol antioxidant, N-acetyl-L-cysteine (NAC, 20mM) which also reduced Ang II-induced O2·− generation to 20%. Serum response factor (SRF) and its co-activator, myocardin (Myo) mediate CArG-dependent transcription of SMα-actin gene. Although Ang II treatment did not modify mRNA for SRF, it increased Myo expression by 22%. Promoter repoter assays indicated that Ang II increased SMα-actin promoter activity by 2.3 fold and this was inhibited by 43% by NAC. Site-directed mutations demonstrated that CArG elements are required for SMα-actin promoter activity. Quantitative chromatin immunoprecipitation assay revealed that Ang II increased SRF enrichment of CArG regions in SMα-actin promoter in intact chromatin by 57%, whereas NAC reduced it by 43% without affecting histone 3 (H3) acetylation or histone 3 lysine-9 (H3K9) dimethylation. In conclution; Ang II induces O2·− in SHR PGSMCs that increases SMα-actin gene expression via up-regulation of Myo and enhanced SRF bound to CArG elements without modifications of H3 acetylation and H3K9 methylation in the SMα-actin promoter regions.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call